Clinical Trials Browser

Terminated × Neoplasms × Melphalan × Clear all

NCT00793650 2012-08-30

Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

Phase 1/2 Terminated

39 enrolled 9 charts

Multiple Myeloma, Neoplasms